What Researchers Did
Researchers conducted a randomized controlled trial comparing normobaric hyperoxia (NBH) and hyperbaric oxygen therapy (HBOT) with a control group in patients with mild traumatic brain injury (TBI).
What They Found
Both NBH and HBOT significantly improved MoCA and MMSE scores and decreased levels of S100β, NSE, GFAP, HIF-1α, MDA, and rSO2 compared to the control group. Patients receiving HBOT demonstrated even higher MoCA and MMSE scores and lower levels of these biomarkers than those in the NBH group.
What This Means for Canadian Patients
Canadian patients with mild traumatic brain injury might experience better cognitive recovery with hyperbaric oxygen therapy (HBOT) compared to normobaric hyperoxia (NBH). This suggests HBOT could be a more effective treatment option to improve cognitive function following mild TBI.
Canadian Relevance
This study was not conducted in Canada and has no direct Canadian connection.
Study Limitations
A limitation of this study is that it was conducted at a single center and had a relatively short follow-up period of 30 days.